Report on evaluation and reclassification of substances on the list of documented traditional Asian substances (TAS list)

8 October 2020 – Following the entry into force of the revision of the legislation on therapeutic products on 1 January 2019, the new legal regulation of self-medication requires an evaluation and reallocation of all substances from the list of documented traditional Asian substances (List TAS), which had previously been classified in delivery category C.

For further information, see here.